Welcome to CrystecPharma
CrystecPharma applies the latest supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical industry, contributing to human health by enabling new and more effective therapies.
Applications of our technology include enhancing the dissolution and bioavailability of drugs, optimising release profiles, as well as improving stability and processing characteristics.
Our solutions include the following:
- Crystal and particle engineering
- Stabilisation of therapeutic agents derived from biotechnology
- Polymorph screening
- Improved performance of poorly soluble drugs
- Inhaled therapy
- Taste masking
- Crystallisation seeds
- Residual solvent elimination
Crystec’s Chief Scientist, Professor Peter York, has been invited to present at the 5th Medicon Valley Inhalation Symposium (MVIS)
Professor Peter York, Crystec’s Chief Scientist, is looking forward to speaking at the upcoming MVIS conference in Lund, Sweden (12th-13th October 2016). The presentation will focus on 'Supercritical Fluid (SCF) Particle Engineering for Optimised Inhaled Delivery'.
August 5 2016
Meet with Crystec at CPhI Worldwide 2016
Crystec will be at CPhI Worldwide in Barcelona (4th – 6th October 2016). Contact Serena Wong (Serena.Wong@crystecpharma.com) to schedule a meeting at the event.
July 15 2016